What We're Reading: Page 2
Industry reads hand-picked by our editors
Mar 27, 2026
-
The New York Times
Kennedy’s Vaccine Agenda Hits Roadblocks, Diminishing His Clout
-
CNBC
Dr. Scott Gottlieb: FDA’s rare disease framework is ‘a very good start’
-
Axios
China’s rise threatens the drug world’s status quo
-
MIT Technology Review
Here’s why some people choose cryonics to store their bodies and brains after death
Mar 26, 2026
Mar 25, 2026
Mar 24, 2026
-
Stat
NIH grant terminations affected women scientists more than men, study finds
-
The New York Times
J. Michael Bishop, Nobel Prize Winner for Cancer Research, Dies at 90
-
The Wall Street Journal
Why Healthcare Is Doing the Heavy Lifting in This Job Market
-
Fast Company
The most innovative biotech companies of 2026
Mar 23, 2026
Mar 20, 2026
Mar 19, 2026
-
ProPublica
How Robert F. Kennedy Jr.’s Vaccine Agenda Risks a Resurgence of Deadly Childhood Plagues
-
The Boston Globe
After a harrowing mental health crisis, a family’s giving to the Broad Institute’s research tops $1 billion
-
Fierce Biotech
Rare disease advocates stage ‘funeral’ at FDA, demand 4 actions of agency and Congress
Previous
